ÂÜÀòÂÒÂ×

David Greenwald, Ph.D., currently serves on the Board of Directors for Advanced Medicine Partners and Aviko Radiopharmaceuticals while holding the position of Chief Executive Officer at Aviko Radiopharmaceuticals. Active in the biotechnology sector, David also contributes to the Boards of Innervace, Apertura Gene Therapy, Jaguar Gene Therapy, and Axovia Therapeutics. As Vice President of Business Development at Deerfield Management, David focuses on identifying investment opportunities and supporting portfolio company growth. David's previous roles include Board membership at the BioTechnical Institute of Maryland and teaching at Johns Hopkins University. David earned a Ph.D. in Genetics from Tufts University School of Medicine and a Bachelor of Science in Cellular Molecular Biology & Genetics from the University of Maryland.